Astatine-211-labeled biotin conjugates resistant to biotinidase for use in pretargeted radioimmunotherapy

Nuclear Medicine and Biology

Volumn 25, Issue 2, 1998, Pages 81-88

  Foulon, Catherine F ^a   Alston, Kevin L ^a   Zalutsky, Michael R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aniline; Astatine; Poiotin; Pretargeting

Indexed keywords

((5 [ASTATINE 211]ASTATO 3 PYRIDINYL)CARBONYL)NORBIOTINAMIDE; (3 [ASTATINE 211]ASTATOBENZOYL)NORBIOTINAMIDE; ANTIBODY CONJUGATE; IODINE 125; MONOCLONAL ANTIBODY; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANCER RADIOTHERAPY; CEREBROSPINAL FLUID; DRUG CLEARANCE; DRUG DEGRADATION; DRUG HALF LIFE; DRUG STRUCTURE; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MOUSE; NONHUMAN; RADIOIMMUNOTHERAPY; SERUM; TISSUE DISTRIBUTION;

AMIDOHYDROLASES; ANIMALS; ASTATINE; BIOTIN; BIOTINIDASE; HUMANS; MICE; MICE, INBRED BALB C; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RADIOPHARMACEUTICALS; STREPTAVIDIN; TISSUE DISTRIBUTION;

EID: 0031962796     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00166-2     Document Type: Article

References (27)

1. 111In-DTPA-biocytin. Nucl. Med. Biol. 23:1996;459-466.
2. Bloomer W. D., McLaughlin W. H., Neirinckx R. D., Adelstein S. J., Gordon P. R., Ruth T. J., Wolf A. P. Astatine-211 tellurium radiocolloid cures experimental malignant ascites. Science. 212:1981;340-341.
3. Breitz M., Ratliff B., Beaumier P., Kunz S., Fritzberg A. Intrapatient comparison of antibody NR-LU-10 pretargeted In-111 with Tc-99m FAB fragment for assessing targeted radiotherapy delivery (abstract). Eur. J. Nucl. Med. 23:1996;1110.
4. Channing M. A., Lang L., Jagoda E., Vera D., Eckelman W. C. Fluorine-18 labeled biotin analogs Potential ligands for antibody-streptavidin conjugates . J. Nucl. Med. 38:1997;142P.
5. Foulon C. F., Adelstein S. J., Kassis A. I. One-step synthesis of radioiodinated biotin derivatives. Bioorg. Med. Chem. Lett. 50:1996;779-784.
6. 211At]astatoanalide . Nucl. Med. Biol. 24:1997;135-143.
7. Foulon C. F., Alston K. L., Zalutsky M. R. Synthesis and preliminary biological evaluation of (3-iodobenzoyl)norbiotinamide and ((5-iodo-3-pyrimidyl)carbonyl)norbiotinamide Two radioiodinated biotin conjugates with improved stability . Bioconj. Chem. 8:1997;179-186.
8. 2 fragment. Cancer Res. 50:1990;3514-3520.
9. Garg S., Garg P. K., Zalutsky M. R. N-Succinimidyl 5-(trialkylstannyl)-3-pyridine carboxylate A new class of reagents for proteins radioiodination . Bioconj. Chem. 2:1991;50-56.
10. Green E. L. Biology of the Laboratory Mouse. 2nd edn. 1966;McGraw-Hill, New York.
11. Green N. M. Avidin. Adv. Protein Chem. 29:1975;85-133.
12. 67Ga deferoxamineacetyl-cysteinylbiotin. Drug Metab. Disp. 23:1995;1362-1367.
13. Hymes J., Wolf B. Biotinidase and its roles in biotin metabolism. Clin. Acta. 255:1996;1-11.
14. Khawli L. A., Chen F.-M., Alauddin M. M., Epstein A. L. Radioiodinated monoclonal antibody conjugates Synthesis and comparative evaluation . Antibody Immunol. Radiopharm. 4:1991;163-182.
15. 125I]Iodoaniline A useful reagent for radiolabeling biotin . Nucl. Med. Biol. 19:1992;297-301.
16. 211At reaction. Appl. Radiat. Isot. 47:1996;135-143.
17. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts Treatment of cutaneous tumors and lymph node metastases . Cancer Res. 52:1992;4385-4390.
18. Ngai W. M., Reilly R. M., Polihronis J., Shpitz B. In vitro and in vivo evaluation of streptavidin immunoconjugates of the second generation TAG-72 monoclonal antibody CC49. Nucl. Med. Biol. 22:1995;77-86.
19. 213Bi]HuM195) in patients with leukemia. J. Nucl. Med. 38:1997;231P.
20. 211At]astatobenzylguanidine on human neuroblastoma cells. Cancer Res. 54:1994;5414-5419.
21. Suormala T., Wick H., Bonjour J.-P., Baumgartner E. R. Intestinal absorption and renal excretion of biotin in patients with biotinidase deficiency. Eur. J. Pediat. 144:1985;21-26.
22. 211At]Astato-2′-deoxyuridine, an α-particle-emitting endoradiotherapeutic agent undergoing DNA incorporation. Cancer Res. 56:1996;1204-1209.
23. Wang K. S., Patel A., Mock D. M. The metabolite profile of radioisotope-labeled biotin in rats indicates that rat biotin metabolism is similar to that in humans. J. Nutr. 126:1996;1852-1857.
24. Weber P. C., Pantoliano M. V., Salemme F. R. Crystallographic and thermodynamic comparison of structurally diverse molecules binding of streptavidin. Acta Crystallogr. 51:1995;590-596.
25. Wilbur D. S., Hamlin D. K., Pathare P. M., Weerawarma W. A. Biotin reagents for antibody pretargeting Synthesis, radioiodination, and in vitro evaluation of water-soluble, biotinidase-resistant biotin derivatives . Bioconj. Chem. 8:1997;572-584.
26. Zalutsky M. R., McLendon R., Garg P. K., Archer G. E., Schuster J. M., Bigner D. D. Radioimmunotherapy of neoplastic meningitis in rats using an α-particle-emitting immunoconjugate. Cancer Res. 54:1994;4719-4725.
27. Zalutsky M. R., Bigner D. D. Radioimmunotherapy with α-particle emitting radioimmunoconjugates. Acta Oncol. 35:1996;373-380.